Andhra Cements Can File NCLT Merger Petition After BSE Letter

Andhra Cements Limited can file an NCLT petition for its merger with Sagar Cements Limited after BSE issued a no-adverse-observation letter on November 5, 2026, provided the scheme is submitted within six months. The proposed all-share merger offers 29 Sagar Cements shares for every 98 Andhra Cements shares held by eligible minority shareholders.

What did BSE permit Andhra Cements to do?

BSE permitted Andhra Cements to submit its proposed amalgamation scheme with Sagar Cements to the National Company Law Tribunal, or NCLT. The exchange issued its observation letter with no adverse observations on November 5, 2026, allowing the scheme to proceed to the tribunal-filing stage.

Andhra Cements disclosed receipt of the letter on November 6 under Regulation 30 of the Securities and Exchange Board of India Listing Obligations and Disclosure Requirements Regulations, 2015. Under the scheme, Andhra Cements is the transferor company and Sagar Cements is the transferee company, with the transaction proposed under Sections 230 to 232 of the Companies Act, 2013.

The letter addresses matters related to listing, delisting and continuous-listing requirements. It does not replace the approvals required from shareholders, creditors, lenders and the tribunal. The company must file the scheme with the NCLT within six months of November 5 for the observation letter to remain valid.

Does BSE’s letter approve the merger?

No, BSE’s letter does not approve or complete the merger between Andhra Cements and Sagar Cements. It records that the exchange has no adverse observations for the purpose of taking the scheme to the NCLT, subject to the stated conditions.

Andhra Cements has said that the amalgamation remains subject to statutory and regulatory approvals under applicable law, including approval by the NCLT. BSE also clarified that the submission of documents or information to SEBI or the exchange must not be treated as a clearance or approval of the scheme itself.

BSE may withdraw its no-adverse-observation position if information provided to it is incomplete, incorrect, misleading or false. Withdrawal is also possible if applicable rules, bye-laws, regulations or listing requirements are contravened. This makes the continuing accuracy of disclosures material through the approval process.

What conditions remain before the NCLT can consider the scheme?

Andhra Cements must obtain no-objection certificates, or NOCs, from lending scheduled commercial banks and financial institutions as a condition of the scheme. The proposed amalgamation is expressly subject to these lender approvals.

The company must also complete the creditor and shareholder processes applicable to the transaction. Before the shareholder process advances, Andhra Cements must receive a report on complaints, examine that report and take necessary measures. Shareholders are to receive three years of revenue, profit after tax and EBIDTA data for both Andhra Cements and Sagar Cements.

Following the filing, Andhra Cements must incorporate SEBI and stock-exchange observations in its NCLT petition and bring those observations to the tribunal’s notice. The sequence reflects the separate roles of exchanges, SEBI, lenders, shareholders, creditors and the NCLT in a listed-company amalgamation.

What are the key dates and merger terms?

The key disclosed dates show that the merger process began with board approval in June and has now reached the NCLT-filing stage. The latest BSE letter creates a filing window rather than an effective date for the transaction.

The merger was approved by the Andhra Cements board on June 5, 2026. Andhra Cements is a subsidiary of Sagar Cements, and the transaction contemplates its merger into the parent company. If the scheme becomes effective after all necessary approvals, Andhra Cements would cease to exist as a separate listed entity.

Why does the filing step matter for investors?

The BSE letter moves the transaction beyond the stock-exchange observation stage, but it does not alter the proposed exchange ratio or make the merger binding. For Andhra Cements shareholders, the stated economic term remains 29 Sagar Cements shares for every 98 Andhra Cements shares held by eligible minority shareholders.

The disclosure does not state any share-price movement, financial valuation or completion date. Investors therefore have a defined regulatory milestone and filing deadline, but not a conclusion to the transaction. The required circulation of three years of revenue, PAT and EBIDTA data is relevant because it provides shareholders with comparative financial information before they consider the scheme.

The transaction also remains exposed to procedural outcomes. Lender NOCs, creditor compliance where applicable, complaint handling, shareholder disclosures and NCLT approval are still pending requirements. BSE’s ability to reconsider its observation position in specified circumstances adds another compliance condition to the process.

Conclusion

Andhra Cements has completed a defined listing-related step after BSE issued a no-adverse-observation letter on November 5, 2026. The letter permits an NCLT filing for the proposed amalgamation with Sagar Cements, but it is not an approval of the merger and does not by itself change the legal status of either company.

The next disclosed milestone is submission of the scheme to the NCLT within six months of November 5, 2026. Investors will need to track lender NOCs, creditor and shareholder procedures, the required financial disclosures for both companies, and the tribunal process before the proposed 29-for-98 share swap can take effect.